Global Enteric Capsules Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Enteric Capsules Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Enteric capsule means capsule can’t be dissolved in gastric juice, but can be disintegrated in intestinal juice and release active ingredients. Since some kinds of medicine have strong stomach irritation or injury effects while they have no harm to intestines, these kinds of medicine should be made into enteric capsule. The shell of enteric capsule is added with special pharmaceutical polymers or accepts special treatment, so that the capsule can’t be dissolved in gastric juice, but can be disintegrated in intestinal juice and release active ingredients.
Enteric Capsules report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Enteric Capsules market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Pharmaceutical and Health Supplements are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Enteric Capsules industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Enteric Capsules key manufacturers include Lonza (Capsugel), Meihua Group, Bright Pharmacaps Inc., Gelita, Snail Pharma Industry Co., Ltd., Shanxi Guangsheng Medicinal Capsule, Shanghai Key Biotechnology, JCCAPS and Anhui Huagnshan Capsule, etc. Lonza (Capsugel), Meihua Group, Bright Pharmacaps Inc. are top 3 players and held % sales share in total in 2022.
Enteric Capsules can be divided into Hydroxypropyl Methylcellulose (HPMC), Gelatin and Vegetable,, etc. Hydroxypropyl Methylcellulose (HPMC) is the mainstream product in the market, accounting for % sales share globally in 2022.
Enteric Capsules is widely used in various fields, such as Pharmaceutical, Health Supplements and Others,, etc. Pharmaceutical provides greatest supports to the Enteric Capsules industry development. In 2022, global % sales of Enteric Capsules went into Pharmaceutical filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Enteric Capsules market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Lonza (Capsugel)
Meihua Group
Bright Pharmacaps Inc.
Gelita
Snail Pharma Industry Co., Ltd.
Shanxi Guangsheng Medicinal Capsule
Shanghai Key Biotechnology
JCCAPS
Anhui Huagnshan Capsule
Qingdao Yiqing Biotech
Jiangsu Lefan Capsule
Shaoxing Kangke Capsule
Zhejiang Yuexi Capsule
Zhejiang Kangping Capsule
Natural Capsules
Segment by Type
Hydroxypropyl Methylcellulose (HPMC)
Gelatin
Vegetable
Pharmaceutical
Health Supplements
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Enteric Capsules market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Enteric Capsules, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Enteric Capsules industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Enteric Capsules in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Enteric Capsules introduction, etc. Enteric Capsules Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Enteric Capsules market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Enteric Capsules report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Enteric Capsules market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Pharmaceutical and Health Supplements are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Enteric Capsules industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Enteric Capsules key manufacturers include Lonza (Capsugel), Meihua Group, Bright Pharmacaps Inc., Gelita, Snail Pharma Industry Co., Ltd., Shanxi Guangsheng Medicinal Capsule, Shanghai Key Biotechnology, JCCAPS and Anhui Huagnshan Capsule, etc. Lonza (Capsugel), Meihua Group, Bright Pharmacaps Inc. are top 3 players and held % sales share in total in 2022.
Enteric Capsules can be divided into Hydroxypropyl Methylcellulose (HPMC), Gelatin and Vegetable,, etc. Hydroxypropyl Methylcellulose (HPMC) is the mainstream product in the market, accounting for % sales share globally in 2022.
Enteric Capsules is widely used in various fields, such as Pharmaceutical, Health Supplements and Others,, etc. Pharmaceutical provides greatest supports to the Enteric Capsules industry development. In 2022, global % sales of Enteric Capsules went into Pharmaceutical filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Enteric Capsules market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Lonza (Capsugel)
Meihua Group
Bright Pharmacaps Inc.
Gelita
Snail Pharma Industry Co., Ltd.
Shanxi Guangsheng Medicinal Capsule
Shanghai Key Biotechnology
JCCAPS
Anhui Huagnshan Capsule
Qingdao Yiqing Biotech
Jiangsu Lefan Capsule
Shaoxing Kangke Capsule
Zhejiang Yuexi Capsule
Zhejiang Kangping Capsule
Natural Capsules
Segment by Type
Hydroxypropyl Methylcellulose (HPMC)
Gelatin
Vegetable
Segment by Application
Pharmaceutical
Health Supplements
Others
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Enteric Capsules market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Enteric Capsules, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Enteric Capsules industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Enteric Capsules in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Enteric Capsules introduction, etc. Enteric Capsules Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Enteric Capsules market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices